The effectiveness of tyrosine kinase inhibitor for chronic myeloid leukemia in tuberous sclerosis. A case report and review of literature

Bibliographic Details
Title: The effectiveness of tyrosine kinase inhibitor for chronic myeloid leukemia in tuberous sclerosis. A case report and review of literature
Authors: Abdulrahman Al‐Abdulmalek, Reem Al‐Suliman, Mohammad Abu‐Tineh, Mostafa Ali, Mohamed A. Yassin
Source: Clinical Case Reports, Vol 11, Iss 3, Pp n/a-n/a (2023)
Publisher Information: Wiley, 2023.
Publication Year: 2023
Collection: LCC:Medicine
LCC:Medicine (General)
Subject Terms: CML, tuberous sclerosis, tyrosine kinase inhibitors, Medicine, Medicine (General), R5-920
More Details: Abstract The relationship between chronic myelogenous leukemia (CML) and tuberous sclerosis (TS) is unusual and uncommon. Here, we report a 24‐year‐old woman diagnosed with TS and later identified with CML, as the second case reported with such coexistence, treated with Nilotinib. This article proposes a hypothesis to explain the association. Therefore, we propose Nilotinib for the treatment of patients with such coexisting diseases. Further studies are warranted to reveal the dynamics between these conditions.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2050-0904
Relation: https://doaj.org/toc/2050-0904
DOI: 10.1002/ccr3.7087
Access URL: https://doaj.org/article/91e468329b24477c9775e1cf0bffb327
Accession Number: edsdoj.91e468329b24477c9775e1cf0bffb327
Database: Directory of Open Access Journals
More Details
ISSN:20500904
DOI:10.1002/ccr3.7087
Published in:Clinical Case Reports
Language:English